That projection starts with first half 2025 semaglutide sales of about $16.4 billion (Ozempic about $9.4 billion, Wegovy roughly $5.4 billion, Rybelsus about $1.7 billion), annualizes that run rate to approximately $33 billion for full-year 2025, and incorporates Novos statement that recent U.S
Xie, Y et al Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation BMJ Medicine, March 18, 2026
Sleep Stack Deep sleep + metabolic recovery support
Guidelines for diagnosis and treatment of alopecia areata in China
And then unfortunately, like really battled being what one called a fat kid
Learn More Exosomes Uses your own plasma to stimulate dormant follicles and enhance hair density naturally